Grace Therapeutics宣布STRIVE-ON三期试验结果摘要获选将在2026年美国神经病学学会年会展示

美股速递
Apr 14

Grace Therapeutics(股票代码:GRCE)近日宣布,其针对STRIVE-ON三期临床试验结果的研究摘要已获接受,将于2026年美国神经病学学会(AAN)年会上进行正式报告。

该摘要重点突出了STRIVE-ON试验的关键数据,这项三期临床研究旨在评估公司某在研疗法的有效性与安全性。此次获选在权威学术会议上展示,标志着该临床试验结果获得了神经病学领域的专业认可。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10